| Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Investing > Choosing And Monitoring Your Investments |
|
Answers - Choosing And Monitoring Your Investments
The issues to consider are:
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ance of achieving growth in the long run but index linked products can be considered for fixed interest investing. ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. duct which must pay out income when you would rather it were left in. here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe Questions to ask about any investment
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro >
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc or taxed? are capital gains taxable?
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi estment: is it fixed or variable?
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically le and to whom?
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ t, remembering that it may not be maintained?
Warning ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi s ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a Read the small print, especially if there are guarantees.
dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod pecially for regular contributions.
Monitoring Your Investments It is essential to keep records of y cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin our investments date of purchase or sale, quantity, price and value.
It is also a good idea to record successive price tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen s of equity investments, where appropriate, so you can spot a trend.
If you have a computer, there are a number of progr t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ams for keeping records and share prices can be downloaded and graphs drawn as an aid to investment decisions, including ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust prospective purchases. You can set a stop loss price for each share held, say 10 or 20% below the purchase price (comput y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products er programs are good at this). You do not have to sell when the price falls below it, especially if the whole market is d . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de own, but it is a signal to review. A good test is whether you would buy at the current price if you did not already have elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip the shares. Another vital record is a diary of future events, such as the date any National Savings certificates expire. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Domain Name System - 4 Steps to Find Your Winning Domain Name Increase On Line Traffic Using Offline Methods How to Choose A Web Hosting Directory
|